by Jordana Choucair | Jan 6, 2023 | Payers
The Federal Trade Commission (FTC) released a proposed rule that would ban employee noncompete contract provisions. The proposed rule is one element of the FTC’s broader strategy to limit anticompetitive activity in health care and other industries. Researchers...
by Jordana Choucair | Jan 4, 2023 | Life Sciences
The Food and Drug Administration (FDA) announced it will allow pharmacies to dispense the abortion medication mifepristone to patients. The agency also said it would no longer enforce a rule requiring people to get the first of the two drugs in person at a clinic or...
by Jordana Choucair | Jan 4, 2023 | Life Sciences
Gilead Sciences Inc. and EVOQ Therapeutics Inc. are partnering to develop autoimmune disorder treatments in a deal worth up to $658.5 million. The companies will collaborate on preclinical work for rheumatoid arthritis and lupus treatments, and Gilead will then...
by Jordana Choucair | Jan 4, 2023 | M&A
The Oregon Health Authority (OHA) approved Amazon’s proposed acquisition of One Medical after conducting a regulatory review. The regulator concluded the acquisition would be unlikely to affect access and cost for Oregonians and ruled out a more comprehensive review...
by Jordana Choucair | Jan 4, 2023 | Payers
The U.S. Department of Health and Human Services (HHS) Office of the Inspector General (OIG) released a report revealing that Medicare lost out on millions of potential savings due to spotty oversight of the average sales price (ASP) of medications. According to the...
Recent Comments